Note:
This interview features a person with a primary immune deficiency.
It was not written by a healthcare professional and is not meant
to replace the expert care of a qualified physician. Please consult
your physician with any questions you might have about your health.
Q: How did you find out that you had a primary
immune deficiency?
Since my birth in 1975, I was considered "sickly."
Failure to thrive, high fevers, bronchitis, pneumonia, meningitis,
and frequent infections punctuated my childhood. I was very small
for my age, weighing only 25 pounds when I entered kindergarten.
Though my parents were attentive to my health problems, the underlying
problem went undiscovered until 1987. When I was 11 years old,
I became increasingly sick as a result of mononucleosis. I ended
up in the hospital, having been diagnosed with a platelet disorder
known as Idiopathic Thrombocytopenic Purpura (ITP).1
My first infusion of intravenous immune globulin (IVIG) to treat
this disorder resulted in anaphylaxis, which is a severe allergic
reaction that can cause difficulty in breathing. My mother brought
me to a research hospital in another state hoping to find answers,
and we did. The IgA2 levels in the original IVIG were the problem.
The doctors began to conduct tests that had never been done before,
and it finally felt like we understood what had been happening
with my health all my life. It was a challenge to piece together
all of the peculiar symptoms and illnesses to see the puzzle as
a whole, but once I found out I had a primary immune deficiency
as well as ITP, it all came together.
To everyone's amazement, the infections stopped almost
immediately after I received treatment with IVIG. At that point,
my doctors realized that I had some sort of primary immune disease.
The treatment makes a world of difference in my health and my
life. It means so much to me that with the right treatment regime
I am able to fight infection better than I could before I was
diagnosed.
Q: How often are you (or your child) infused?
Julia: My daughter should be infused every
four to six weeks, but she sometimes waits as long as three months
due to conflicts with her dual diagnosis of ITP and primary immune
deficiency. If she is treated for her primary immune deficiency
while her platelets are still at a normal level, she will be at
risk for a high platelet count. Maintaining a balance in her treatment
regimen is essential.
Her IVIG is infused intravenously through a port in her arm. The
treatment is always administered in the hospital because she is
sensitive to products containing a contaminant3 known as IgA.
Evin: My treatment lasts for about 24 hours.
I usually go to the doctor to get my blood count checked and to
pick up my orders. The hospital orders detail all the medications,
pre-medications, diet, and other details required for my treatment.
When I get to the hospital, I settle into my room and order my
meals for the day. With my food allergies, I need to be careful
about my diet. Once my IV is hooked up to my port and my treatment
is started, I relax. Usually, I spend the infusion time reading,
watching TV, surfing on the Internet, using my laptop, or sleeping.
Q: What has been your experience with your
immunologist?
Evin: I have been so pleased with my physicians'
level of care for my illness and me. My hematologist has been
overseeing my treatment regime for 12 years. I actually found
him through the phone book! When we interviewed with him, he had
a good sense of humor and a positive perspective, which are two
of the qualities I appreciate in a doctor. We work together to
fine-tune my orders to create the most effective and comfortable
infusion possible.
I was referred to my current immunologist/allergist four years
ago. He helps keep my allergic reactions to IgA to a minimum,
while following my illness and aggressively treating my infections.
Both are more than just doctors managing my medical care–––I
feel like they actually care.
Q: Have any organizations or support groups
helped you cope with this chronic disease?
Evin: It's been a huge comfort just knowing
that there are other patients dealing with many of the same medical
issues that I face.
Julia: The
Immune Deficiency Foundation (IDF)4 has provided
us with the chance to meet others with many forms of primary immune
disease. It's amazing how much we have in common, even though
the various diseases have different symptoms. The
Jeffrey Modell Foundation (JMF)5 has also helped
a lot. Through their Web site, Evin and I have learned a lot about
symptoms and support.
I wish these two organizations had been around when she was young.
Evin would have been diagnosed much earlier and suffered much
less. Because there was no Internet when she was young, most of
my research was done on my own through medical textbooks and journals.
The Internet has made medical information more accessible and
much easier to search by a specific topic. Though it does require
that I evaluate the facts more often, since not all Web sites
are created equal.
Q: What's the most difficult part about
living with a primary immune deficiency (or caring for a child
who does)?
Evin: The limitations. My illness does not
hinder my dreaming and wishing for various life accomplishments
and joys, but it does take away some of the energy I need to go
out and fulfill these dreams. This has been difficult, but also
a gift. I constantly remind myself to include things that make
me happy in my daily life and to strive to learn from my illness
and the experiences it offers me. My illness has opened doors,
allowing me to meet many interesting people and develop a good
sense of priorities and patience.
The other thing I find to be most difficult is that on the outside,
I look like any other 20-something woman. Sometimes it makes it
harder for new acquaintances to grasp my restrictions. On a day-to-day
basis, I need to be careful about what I eat and about getting
enough rest.
Another restriction is that I can't always make long-range
plans, because I might need to be in the hospital for a treatment.
When someone tells me that taking an extra vitamin or altering
my habits or diet will cure me, I just have to remember that the
person means well and I know better. Though it is sad that not
everyone is better educated about immune deficiency, it is sweet
that people have such hope for me to find good health.
Julia: Probably the most difficult thing was
convincing her doctors that what looked like a cold would not
stay that way. Before diagnosis and treatment for her primary
immune deficiency, Evin's infections would worsen rapidly—so
her sore throat at noon could turn into respiratory distress by
midnight. Luckily, her first pediatrician always treated her infections
aggressively.
When she developed meningitis as a toddler, I went to the emergency
room and was sent home three times. The doctor thought Evin had
the flu and didn't believe mothers were competent to make
medical "diagnoses." As a result, I have learned to
be a strong advocate for my daughter, for others, and for myself.
I am often asked to accompany my friends to the hospital to advocate
for them.
The company that produces the therapy Evin receives has also
been incredibly supportive. I first contacted them when she was
having a problem getting her therapy. Everyone involved in Evin's
treatment regimen keeps in touch by e-mail and phone to be sure
that she is doing well. In addition, we have been lucky enough
to meet the people who produce the therapy and arrange for shipment.
Q: What advice would you give a person newly
diagnosed with a primary immune deficiency (or the parent of one)?
What advice would you give to that person's family?
Evin: Listen to your gut. If you are told something,
but it just doesn't sit right with you, do your own research
or get a second opinion. Learn to read test results so you can
stay informed.
Julia: Don't panic. Primary immune disease
is treatable. Find a competent physician. (The Jeffrey Modell
Foundation or the Immune Deficiency Foundation can help with this.)
And, most of all, take each day as it comes.
Q: Describe your experience with your insurance
company?
Julia: Until our daughter turned 25, she was
covered under our policy. Since then, we have had to purchase
an individual policy, which is expensive and does not cover her
treatment well. Because she has several conditions that complicate
her health, she is unable to work full-time right now. We are
looking for other coverage to alleviate some of the out-of-pocket
expenses associated with this policy. Insurance can be a frustration
in managing chronic illness, but I try not to get overwhelmed
by it.
Q: Is there any "silver lining"
to having this condition?
Evin: Understanding chronic illness and its
effects on daily life has given me the ability to empathize with
others—something that I cherish. I used to be very shy,
but having to be an advocate for my health and welfare on a daily
basis has encouraged me to be more assertive and outgoing. I have
an interesting perspective on life that I've gained through
my experience with chronic illness, and that is a part of who
I am. I have squelched my shyness to the point that I am able
to make speeches to large and small groups on behalf of different
organizations.
Julia: It has brought our family closer together
and given us a real perspective on what is important in life.
We operate as a team, with all of us pulling together. Since Evin
is an only child, we have been able to focus a lot on supporting
her and have spent more time together than most families do. We
have met wonderful people: other patients, families, doctors,
nurses, and pharmaceutical company representatives. Our family
is much stronger.
Q: What improvements in your IVIG would you
like to see from processors of IVIG therapies?
Evin: I wish for a treatment regimen that makes
life more accessible. I would like to see more progress in eliminating
IgA from my therapy.
Julia: I would like to maintain the current
confidence we have about the purity of the product we use. It
would be wonderful to have a product with no IgA so we can eliminate
allergic reactions. An educational program for physicians and
hospital staff—especially pharmacists—would be great.
Not everyone is informed about the needs of a patient with a primary
immune deficiency and additional training in drug sensitivity,
caring for patients with chronic illnesses, and being prepared
for regular hospital admissions would be an asset to the field
of medical care.
References:
1. IgA is an antibody that is part of the
normal immune system. Some immune-deficient patients have anti-IgA
antibodies and, as a result, might suffer from an allergic reaction
to IVIG preparations that contain high levels of IgA.
2. Although IgA is a naturally occurring antibody
in the normal immune system, it is considered a contaminant in
an IVIG preparation that will be infused in immune-deficient patients.
3. ITP is a disorder of the blood in which
the number of platelets (blood cells involved in clotting) is
reduced. As a result of low platelet counts, excessive bleeding
can occur. (This definition was adapted from the Jewish Hospital
Healthcare Services Web site, at www.jhhs.org.)
4. The IDF is a patient organization whose
mission is to improve the diagnosis and treatment of patients
with primary immunodeficiency disease through research and education.
The IDF Web site address is www.primaryimmune.org.
5. The Jeffrey Modell Foundation is a patient
organization that is active in research, physician and patient
education, patient support, and public awareness. The foundation's
Web site address is www.jmfworld.org.
View MyStory archive
top of page